Venture&Growth
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
Splice Bio is a biotech company based on intein technologies developed in the Muir Lab at Princeton University. They are working with their proprietary platform to address key limitations of current gene therapy approaches to treat patients in need. The company is building a product pipeline of gene therapies targeting inherited retinal diseases and other severe genetic diseases for which there is no cure.
More Splice Bio news
Noema Pharma
Noema Pharma is a Swiss biotech company developing ground-breaking therapies to address the most disabling...

Ablative Solutions
Ablative Solutions is a medical device company that has developed a best-in-class drug delivery catheter,...

Nyxoah
Nyxoah S.A. is a Belgian healthtech company focused on the development and commercialization of innovative...
